Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021
Authors:
- 19 January 2022
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22 (7) , 442-459
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Review of health-related quality of life data in multiple myeloma patients treated with novel agentsLeukemia, 2013
- Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standardsQuality of Life Research, 2012
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple MyelomaNew England Journal of Medicine, 2012
- Responsiveness and minimal important score differences in quality‐of‐life questionnaires: a comparison of the EORTC QLQ‐C30 cancer‐specific questionnaire to the generic utility questionnaires EQ‐5D and 15D in patients with multiple myelomaEuropean Journal of Haematology, 2011
- First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialThe Lancet, 2010
- Health related quality of life in a nationally representative sample of haematological patientsEuropean Journal of Haematology, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision makingAnnals of Oncology, 2007
- Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differencesEuropean Journal of Haematology, 2004
- Beyond the Development of Health-Related Quality-of-Life (HRQOL) Measures: A Checklist for Evaluating HRQOL Outcomes in Cancer Clinical Trials—Does HRQOL Evaluation in Prostate Cancer Research Inform Clinical Decision Making?Journal of Clinical Oncology, 2003